United Kingdom


GW Pharma initiates Phase 3 study of Epidiolex in Dravet syndrome

London, UK, 31 March 2015: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces it has initiated the Phase 3 part of a Phase 2/3 clinical trial of Epidiolex® (cannabidiol or CBD) for the treatment of Dravet syndrome, a rare and catastrophic treatment-resistant form of childhood epilepsy. GW anticipates that top-line data from this trial will be available around the end of 2015.


Sir Richard Branson on Ending the war on drugs, the challenges and opportunities ahead

Last week’s Vienna meeting of the UN’s Commission on Narcotic Drugs was an important stepping stone on the road to 2016, when world leaders will come together in New York to discuss drug policy in a special session of the UN General Assembly, also known as the UNGASS.

As dry as these diplomatic gatherings appear, they play a key role in our effort to end the war on drugs; try new approaches to drug policy that reduce harm; end the criminalisation of drug users and keep non-violent drug offenders out of prison; and treat drugs overall as a health issue. 


Hemp Based Batteries Could Change The Way We Store Energy Forever

As hemp makes a comeback in the U.S. after a decades-long ban on its cultivation, scientists are reporting that fibers from the plant can pack as much energy and power as graphene, long-touted as the model material for supercapacitors. They’re presenting their research, which a Canadian start-up company is working on scaling up, at the 248th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society.

Although hemp (cannabis sativa) and marijuana (cannabis sativa var. indica) come from a similar species of plant, they are very different and confusion has been caused by deliberate misinformation with far reaching effects on socioeconomics as well as on environmental matters.


Pro-cannabis party to stand in Edinburgh

A NEW political party campaigning for the legalisation of cannabis is to field a candidate in the Capital at the general election.

Cista – which stands for Cannabis Is Safer Than Alcohol – was set up just last month but plans to contest around 40 seats across the UK on May 7, including Edinburgh South West, where former Chancellor Alistair Darling is standing down.

Party leader Paul Birch, who co-founded social networking site Bebo before it was sold to AOL for £570 million, said Britain’s drug laws were “pretty messed up right now”.

He said: “There has been a lot of progress in other countries – there 700 cannabis social clubs in Spain, cannabis has been legalised in four American states and the number is growing every year.


Man Killed by Cannabis Story on DailyMail Website Wins Orwellian Prize

The article in the DailyMail states that a man died after suffering heart problems as a result of a decade-long addiction to cannabis, an inquest heard.

“John O’Brien, 53, from Salford, began smoking cannabis to cope with life-changing brain injuries sustained in a car crash.

But over a ten-year period, the Class B drug took its toll on his body and caused his heart to stop working.

A coroner at Bolton Coroner’s Court ruled in December 2014 that Mr O’Brien died from cannabis cardiotoxicity, a little known condition in which smoking cannabis triggers heart problems.”


Forget the hysteria. Here are the facts about 'cannabis psychosis'

Charles Walker MP, Parliament’s cheerleader for the ‘skunk scaremongers’ shot himself and his hysterical campaign in the foot this week.

He had submitted a parliamentary written question asking: "How many people under 18 years of age have been treated in NHS-funded mental health units for cannabis-induced psychosis in each of the last five years?”

The answer from Jane Ellison MP, minister of state at the Department of Health, must have gravely disappointed Mr Walker. She revealed there have been average of just over 28 ‘finished admission episodes’ for each of the past five years. That doesn’t necessarily mean 28 people as it could include the same person being admitted more than once.


UK Cannabis debate: Politicians and campaigners on highs and lows of legalisation

’ve spoken to dozens upon dozens of people about whether or not some drugs should be legalised – those for, those against – and there are some undeniably valid opinions on both sides.

I want to lay bare the truth of these conversations, outlining the most salient arguments, and see where the dust settles.

Last week MM spoke to pro-cannabis campaigner Colin Davies, who believes Manchester should use the extra powers offered through ‘devo-Manc’ to become the UK’s first cannabis decriminalisation trial.

Standby also for the thoughts of former Labour spin doctor Alastair Campbell and the leader of the Pirate Party UK, Loz Kaye.


'You’re naive, stupid and useless at growing cannabis' says Judge


A BODGED cannabis farmer has been spared jail because he was useless at growing the crop.

Stephen Thompson was caught with 30 plants, a high powered lamp and an oil filled radiator hidden in the loft of his home in Liverpool Road, Penwortham.

The plants were riddled with mites and the lighting was so poor forensic scientists said the crop would not have survived to full maturity.


Recorder Craig Sephton, sentencing, told him: “You were naive, stupid and useless at growing cannabis.”


UK: Treat cannabis the same as alcohol and tobacco, says Bristol MP Stephen Williams

Bristol West MP Stephen Williams says it's his personal wish to give cannabis the same legal status as alcohol and tobacco.

He argues that if you look at the hierarchy of harm caused by substances, you could not say cannabis was more harmful than alcohol.

"It terms of the damage alcohol does, in terms of domestic violence and crime, its far more harmful than cannabis," he says.

On whether this could lead to an increased culture of drug use, comparable to alcohol, he said that the main problem behind binge drinking was a pricing issue, with supermarkets able to sell alcohol too cheaply.



GW Pharmaceutical (GWPH: NASDAQ) has quietly outperformed most of its fellow NASDAQ companies during 2015 and Technical420 has been recommending them the whole time. GWPH is up over 10% today and over 36% this year. The company manufactures and sells the first prescribed cannabis-based medicine in over 20 countries and its deep product pipeline will lead to incremental revenue growth for years to come.

A pharmaceutical, not marijuana, company


Subscribe to RSS - United Kingdom